23andMe Holding (formerly known as VG Acquisition) is a consumer genetics and research company. It aims to help individuals to understand their genetic information through DNA analysis technologies and web-based interactive tools. The company operates through Consumer and Research Services and Therapeutics segments. The Consumer and Research Services business segment comprises personal genome service (PGS), telehealth business, and research services. The Therapeutics segment focuses on the use of genetic insights from the database of genetic and phenotypic information.